Be Clinical Secures Seed Funding for Advanced Anti-Ageing Solutions

Be Clinical, a skincare brand, has successfully acquired Rs 2 crore in a seed funding round directed by Titan Capital, with contributions from P-TAL founder Aditya Agarwal. The funding will be directed towards internalising manufacturing processes, enhancing inventory oversight, boosting operational efficiency, and safeguarding proprietary formulations, as stated by Be Clinical in a press release.

About Be Clinical

Founded by Himangi Dhir, Be Clinical operates as a science-driven skincare brand aimed at delivering effective anti-ageing solutions. The brand uses medical-grade formulations alongside clinical expertise to provide products that are results-oriented, supporting skin longevity throughout various life stages. Be Clinical is dedicated to principles of transparency, effectiveness, and innovation.

Expansion and Future Plans

This Mumbai-based company aims to advance its mission of providing superior, targeted anti-ageing solutions while establishing new standards for quality and transparency in the skincare industry. The brand is poised to delve into more anti-ageing categories, thereby broadening its selection of clinically validated options focused on skin longevity.

Targeting Gen Z and Millennial Consumers

Be Clinical addresses a significant and increasing demand among Indian Gen Z and Millennial consumers, who are now looking for effective, targeted solutions earlier in their skincare journey.